| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | dBET1 |
|---|
| Description | A hybrid molecule that combines (+)-JQ1 and thalidomide; induces cereblon-dependent BET protein degradation in vitro (EC50 = 430 nM) and in vivo and delays leukemia progression in mice |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | JQ-1 JQ1 lenalidomide bromodomain BET transcriptional activator proteasomal degradation phthalimides cereblon E3 leukemia PROTAC proteolysis target chimera |
|---|
| Gene, Accession, CAS # | CAS: 1799711-21-9 |
|---|
| Catalog # | 18044-10 |
|---|
| Price | |
|---|
| Order / More Info | dBET1 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|